Abstract Details
|
Samuel Asanad
(UCLA David Geffen School of Medicine)
PRESENTER |
No disclosure on file |
| Sidney Starkman, MD, FÂ鶹´«Ã½Ó³» (UCLA Emergency Medicine Center) | No disclosure on file |
| Scott Hamilton | No disclosure on file |
| Robin A. Conwit, MD, FÂ鶹´«Ã½Ó³» | Dr. Conwit has nothing to disclose. |
| Nerses Sanossian, MD, FÂ鶹´«Ã½Ó³» (Department of Neurology, USC) | Dr. Sanossian has received personal compensation for serving as an employee of Univeristy of Southern California. Dr. Sanossian has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Sanossian has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Sanossian has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Portola. The institution of Dr. Sanossian has received research support from Diffusion Pharma. |
| Jeffrey L. Saver, MD, FÂ鶹´«Ã½Ó³» (UCLA Health) | Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stryker. Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cerenovus. Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boehringer Ingelheim (prevention only). Dr. Saver has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Medical Association. Dr. Saver has received stock or an ownership interest from Rapid Medical. |